Publication Name	World Journal of Gastroenterology
Manuscript ID	63181
Country	United Kingdom

Received	2021-01-25 22:34
Peer-Review Started	2021-01-25 22:37
To Make the First Decision
Return for Revision	2021-03-29 04:43
Revised	2021-04-11 21:40
Second Decision	2021-08-03 03:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-08-03 06:14
Articles in Press	2021-08-03 06:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-08-14 07:56
Publish the Manuscript Online	2021-08-18 08:08

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach
Manuscript Source	Invited Manuscript
All Author List	Srujan Rajesh, Michael J Cox and Franscois Runau
ORCID	Author(s) ORCID Number Srujan Rajesh http://orcid.org/0000-0002-1313-1101 Michael J Cox http://orcid.org/0000-0002-3264-6709 Franscois Runau http://orcid.org/0000-0001-6778-459X
Funding Agency and Grant Number
Corresponding Author	Franscois Runau, FRCS (Gen Surg), PhD, Academic Fellow, Surgeon, Department of General Surgery, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, United Kingdom. franscois_gerald@yahoo.com
Key Words	Pancreatic ductal adenocarcinoma, Pancreatic adenocarcinoma; Genomic; Proteomic; Metabolomic
Core Tip	Treatment for pancreatic ductal adenocarcinoma is limited by the severity of the pathology, limited biomarkers and late presentation of patients. Utilising genomic, proteomic and metabolomic research into pancreatic ductal adenocarcinoma has provided insight into understanding the disease process as well as providing suitable markers of diagnosis and treatment to improve clinical outcomes.
Publish Date	2021-08-18 08:08
Citation	Rajesh S, Cox MJ, Runau F. Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach. World J Gastroenterol 2021; 27(31): 5171-5180
URL	https://www.wjgnet.com/1007-9327/full/v27/i31/5171.htm
DOI	https://dx.doi.org/10.3748/wjg.v27.i31.5171

Full Article (PDF)	WJG-27-5171.pdf
Full Article (Word)	WJG-27-5171.docx
Manuscript File	63181_Auto_Edited-JPY.docx
Answering Reviewers	63181-Answering reviewers.pdf
Audio Core Tip	63181-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	63181-Conflict-of-interest statement.pdf
Copyright License Agreement	63181-Copyright license agreement.pdf
Supplementary Material	63181-Copyright permission.pdf
Peer-review Report	63181-Peer-review(s).pdf
Scientific Misconduct Check	63181-Bing-Liu M-1.png
Scientific Misconduct Check	63181-Bing-Liu M-2.png
Scientific Misconduct Check	63181-Scientific misconduct check.pdf
Scientific Editor Work List	63181-Scientific editor work list.pdf